Skip to content

Controlled prospective study to evaluate the inpatient naturopathic fasting therapy in overweight and obese patients

Controlled prospective study to evaluate the inpatient naturopathic fasting therapy in overweight and obese patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00006343
Enrollment
68
Registered
2014-11-24
Start date
2007-08-13
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66 I10 I11 E78 R63.2 F50.4

Interventions

Group 1: At the naturopathic department fo Blankenstein hospital the modified Buchinger fasting therapy is applied including vegetable stocks and vegetable juices, teas and water, but no fruit juices.

Sponsors

Abt. für Naturheilkunde, Klinik Blankenstein
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged from 18 to 75 years, who were overweight (BMI 25-29.9 kg / m²) or obese (BMI = 30 kg / m²), wished to reduce body weight and who were prescribed fasting therapy or a weight reduction diet as a form of nutritional therapy and gave informed consent were included.

Exclusion criteria

Exclusion criteria: We excluded pregnant and lactating women and patients who participated in another study simultaneously or in an organized weight-reduction program or took a medicament against obesity. Further exclusion criteria were: condition after extensive bowel resection or bariatric treatment, inflammatory bowel disease, malignant neoplastic disease, postoperative nutritional deficit, hepatic or renal failure, insulin-dependent diabetes mellitus, not compensated hypothyroidism or hyperthyroidism, coronary heart disease or acute or chronic cardiac arrhythmia, eating disorders like anorexia nervosa, bulimia or binge-eating disorder, severe psychiatric disorders, addictive disorders and dementia.

Design outcomes

Primary

MeasureTime frame
The primary objective of the present study is the weight loss after 6 months of patients who received in-patient fasting treatment in comparison to those receiving a weight reduction diet. A mean difference of 3 kg between the treatment groups was considered clinically significant: A permanent reduction of 5% of the starting weight is considered a success and a general goal of therapy in both German and U.S. American guidelines.

Secondary

MeasureTime frame
• Which percentage of the patients achieve a weight loss of = 5% of the initial weight after fasting therapy or weight reduction diet ? Are there group differences after 6 months ? • What is the development of systolic and diastolic blood pressure during fasting and weight reduction diet, and after 6 months ? Are there differences between patient groups ? • How develop serum concentrations of total, LDL- and HDL-cholesterol, triglycerides and glucose during fasting and weight reduction diet ? How change these parameters after 6 months, and are there differences between the patient groups ? • How does eating behaviour change in the dimensions cognitive control, , distractibility and hunger feelings 3 and 6 months after fasting and weight reduction diet ? Are there differences between the patient groups ? [FEV] • How changes physical activity, measured by duration of acivity in basic, leisure time and sportive activity ? Are there differences between the patient groups ? [FFKA] • Is there a relation between possible raised physical activity and loss of weight after 6 months ? • How changes quality of life 3 and 6 months after fasting and weight reduction diet ? Are there differences between the patient groups ? [SF-12] • Is there a relation between possible increased quality of life and loss of weight after 6 months ?

Countries

Germany

Contacts

Public ContactAndré-Michael Beer

Abt. f. Naturheilkunde, Klinik Blankenstein, ,

andre.beer@klinik-blankenstein.de02324/396-487

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026